|
WO2021081236A1
|
|
Triple function adeno-associated virus (aav) vectors for the treatment of c9orf72 associated diseases
|
|
WO2021081203A1
|
|
Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disorders
|
|
WO2021081201A1
|
|
Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegeneative diseases or disorders
|
|
US2021095313A1
|
|
Adeno-associated virus (aav) systems for treatment of genetic hearing loss
|
|
CA3084802A1
|
|
Formulation optimization for viral particles
|
|
AU2015202707A1
|
|
Recombinant virus production using mammalian cells in suspension
|
|
AU2015247777A1
|
|
Codon optimized nucleic acid encoding a retinitis pigmentosa GTPase regulator (RPGR)
|
|
EP2661494A2
|
|
Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases
|
|
AU2009209408A1
|
|
Recombinant virus production using mammalian cells in suspension
|
